Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach.
Andrea Pires DaminMaira ZancanMarcia P MeloJorge V BiazusPublished in: Breast cancer research and treatment (2020)
SLNB could be successfully used in guiding a more selective axillary approach in cN+ patients that became cN0 after NAC. Omitting ALND in CN0 patients with negative SLNs did not seem to compromise disease control and oncological outcomes.
Keyphrases
- sentinel lymph node
- neoadjuvant chemotherapy
- lymph node
- positive breast cancer
- early stage
- locally advanced
- lymph node metastasis
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- transcription factor
- squamous cell carcinoma
- peritoneal dialysis
- type diabetes
- metabolic syndrome
- radical prostatectomy
- robot assisted